Drug intelligence / Profile preview

Physiologica

Development stage
Unknown
Lead developer
Qualiphar
Modality
Small Molecules
Administration
Intranasal, Ophthalmic, Topical
01

Overview

Physiologica is a line of over-the-counter (OTC) nasal and ocular hygiene products developed and marketed by the Belgian healthcare company Qualiphar. The product range primarily consists of sterile saline solutions (sodium chloride) available in both isotonic (0.9%) and hypertonic (typically 2.3%) concentrations. These products are designed for the mechanical clearance of nasal passages, moisturizing the nasal mucosa, and providing relief from nasal congestion associated with the common cold, rhinitis, and sinusitis. Some specialized formulations, such as Physiologica Septinasal, include additional ingredients like copper sulfate and thyme extract to provide mild antiseptic and soothing properties. The solution works by thinning mucus and physically washing away allergens, irritants, and atmospheric pollutants from the nasal cavity or eyes. It is suitable for use in infants, children, and adults.

Brand names
PhysiologicaPhysiologica IsonasalPhysiologica HypernasalPhysiologica Septinasal
Other names
saline solutionphysiological waterfysiologisch watereau physiologique
02

Targets

ClC (CLC chloride channel family)

Beyond the preview

Go deeper on Physiologica.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Physiologica.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call